Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Jutant (Paris, France), C. Malka Ruimy (Paris, France), A. Beurnier (Paris, France), A. Belguendouz (Paris, France), M. Preda (Paris, France), X. Jaïs (Paris, France), L. Savale (Paris, France), G. Garcia (Paris, France), M. Humbert (Paris, France), O. Sitbon (Paris, France), D. Montani (Paris, France). Prevalence of hyperventilation syndrome in pulmonary arterial hypertension. 1535

Member's Comments

No comment yet.

Related content which might interest you: The metabolic syndrome and pulmonary hypertension Source: Virtual Congress 2020 – Pulmonary vascular diseases Year: 2020 Pulmonary hypertension in hypoventilation syndromes Source: Eur Respir J 2014; 43: 12-15 Year: 2004 Pulmonary hypertension in children Source: Eur Respir Mon 2012; 57: 94-107 Year: 2012 Exercise pathophysiology in patients with pulmonary arterial hypertension Source: Annual Congress 2007 - Mechanisms of exercise intolerance in cardiorespiratory disease Year: 2007 Arterial stiffness in patients with chronic obstructive pulmonary disease combined with arterial hypertension Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020 Arterial blood gases during exercise in chronic obstructive pulmonary disease with and without pulmonary hypertension Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease Year: 2011 Long-term efficacy of bosentan in treatment of pulmonary arterial hypertension in children Source: Eur Respir J 2011; 37: 70-77 Year: 2011 Pulmonary arterial hypertension in children Source: Eur Respir J 2003; 21: 155-176 Year: 2003 Exertional dyspnoea in pulmonary arterial hypertension Source: Eur Respir Rev, 26 (145) 170039; 10.1183/16000617.0039-2017 Year: 2017 Pathophysiology of pulmonary hypertension Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2017 Pathophysiology of pulmonary hypertension Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease Year: 2012 Pathophysiology of pulmonary hypertension Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2014 Pathophysiology of pulmonary hypertension Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease Year: 2018 Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology Source: Eur Respir Rev 2009; 19: 59-63 Year: 2010 Comparison of prevalence of diabetes mellitus in patients with idiopathic pulmonary arterial hypertension and distal chronic thromboembolic pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers Year: 2013 Pulmonary function in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010 Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 53 (6) 1802004; 10.1183/13993003.02004-2018 Year: 2019 Diagnosing pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension Year: 2015 Changing demographics of pulmonary arterial hypertension in congenital heart disease Source: Eur Respir Rev 2010 19: 308-313 Year: 2010